Molecular pharmacokinetic studies of drug transport in endotoxemia

内毒素血症药物转运的分子药代动力学研究

基本信息

项目摘要

First, the effect of pioglitazone, a potent PPAR-γ ligand, on the endotoxin-induced reduction of cytochrome P450 (CYP) was investigated. Second, the role of TNF-α in the down-regulation of hepatic P-glycoprotein and CYP3A2 and CYP2C11 by endotoxin was investigated using TNF-α-knockout mice. Third, the differential effects of endotoxin derived from various gram-negative bacteria on the expression of hepatic CYP3A2, CYP2C11, P-glycoprotein and Mrp2 were investigated.1. Pretreatment with a potent PPAR-γ ligand, pioglitazone, significantly protected the endotoxin-induced decreases the protein levels of CYP3A2, but not CYP2C11, with no biochemical and histopathological changes in the liver. Also, it significantly protected endotoxin-induced overexpression of iNOS in the liver, but not the overproduction of NO in plasma. It is unlikely that the protective effect of pioglitazone against endotoxin-induced decreases in the protein levels of CYP3A2 in the liver is due to the inhibition of the ov … More erproduction of NO.2. Endotoxin had no effect the expression of P-glycoprotein in TNF-α-knockout mice, suggesting that TNF-α plays a pivotal role in the down-regulation of P-glycoprotein by endotoxin. Endotoxin-induced decreases in the expression of CYP3A2 and CYP2C11 in TNF-α-knockout mice were significantly greater than wild-type mice. These results suggest that TNF-α plays a key role in endotoxin-induced down-regulation of hepatic P-glycoprotein, as well as plays a protective role in the regulation of hepatic CYP3A2 and CYP2C11 against endotoxin-induced acute inflammatory.3. The down-regulation of CYP3A2 by K pneumonia and E. coli endotoxin was greater than that by P. aeruginosa endotoxin. But that of CYP2C11 by all three different endotoxin was almost the same. Both K pneumonia and P. aeruginosa endotoxin significantly down-regulated P-glycoprotein, but did not down-regulate Mrp2. E. coli endotoxin had no effect on the expression of either P-glycoprotein or Mrp2. These results suggest that endotoxin has a differential effect on the protein levels of hepatic CYP3A2 and P-glycoprotein, probably due to bacterial source-differences in the production of some proinflammatory mediators Less
首先,研究了吡格列酮(一种有效的PPAR-γ配体)对内毒素诱导的细胞色素P450(CYP)还原的影响。第二,使用TNF-α基因敲除小鼠研究TNF-α在内毒素下调肝脏P-糖蛋白和CYP 3A 2和CYP 2C 11中的作用。第三,研究了不同革兰氏阴性菌来源的内毒素对肝脏CYP 3A 2、CYP 2C 11、P-糖蛋白和Mrp 2表达的不同影响.用有效的PPAR-γ配体吡格列酮预处理可显著保护内毒素诱导的CYP 3A 2蛋白水平降低,但不能保护CYP 2C 11蛋白水平降低,肝脏中无生化和组织病理学变化。此外,它显着保护内毒素诱导的iNOS在肝脏中的过度表达,但不是在血浆中NO的过度产生。吡格列酮对内毒素诱导的肝脏CYP 3A 2蛋白水平降低的保护作用不太可能是由于抑制过氧化氢酶, ...更多信息 生产NO.2。内毒素对TNF-α基因敲除小鼠P-糖蛋白表达无影响,提示TNF-α在内毒素下调P-糖蛋白表达中起重要作用。TNF-α敲除小鼠中内毒素诱导的CYP 3A 2和CYP 2C 11表达降低显著大于野生型小鼠。提示TNF-α在内毒素诱导的肝脏P-糖蛋白表达下调中起关键作用,并在调节肝脏CYP 3A 2和CYP 2C 11对抗内毒素诱导的急性炎症中起保护作用.肺炎克雷伯菌和大肠杆菌对CYP 3A 2的下调作用。大肠杆菌内毒素的作用大于铜绿假单胞菌内毒素。而三种内毒素对CYP 2C 11的影响几乎相同。肺炎克雷伯菌和铜绿假单胞菌内毒素均显著下调P-糖蛋白,但不下调Mrp 2。E.大肠杆菌内毒素对P-糖蛋白和Mrp 2的表达均无影响。这些结果表明,内毒素对肝脏CYP 3A 2和P-糖蛋白的蛋白水平有不同的影响,这可能是由于细菌来源-某些促炎介质产生的差异。

项目成果

期刊论文数量(47)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
長谷川 高明: "新しい図解薬剤学"南山堂. 600 (2003)
长谷川贵明:《新药房图鉴》南山堂 600 (2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Role of tumor necrosis factor-α in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin
  • DOI:
    10.1016/j.ejphar.2004.11.035
  • 发表时间:
    2005-01-10
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Miyoshi, M;Nadai, M;Hasegawa, T
  • 通讯作者:
    Hasegawa, T
Effect of pioglitazone on endotoxin-induced decreases in hepatic drug-metabolizing enzyme activity and expression of CYP3A2 and CYP2C11
吡格列酮对内毒素诱导的肝脏药物代谢酶活性及CYP3A2和CYP2C11表达降低的影响
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ueyama;J.
  • 通讯作者:
    J.
Application of ultrafiltration method to measurement of catecholamines in plasma of human and rodents by high-performance liquid chromatography.
超滤法高效液相色谱法测定人和啮齿动物血浆中儿茶酚胺的含量
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ueyama;J.;Kitaichi;K.;Iwase;M.;Takagi;K.;Takagi;K.;Hasegawa;T.
  • 通讯作者:
    T.
J.Ueyama: "Application of ultrafiltration method to measurement of catecholamines in plasma and rodents by high-performance liquid chromatography"J.Chromatogr.B. 798. 35-41 (2003)
J.Ueyama:“超滤法在高效液相色谱法测定血浆和啮齿动物中儿茶酚胺的应用”J.Chromatogr.B.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HASEGAWA Takaaki其他文献

HASEGAWA Takaaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HASEGAWA Takaaki', 18)}}的其他基金

Realization of Pedestrian Navigation Environments Based on Mobile/Infrastructure Collaborative Operation
基于移动/基础设施协同运行的行人导航环境的实现
  • 批准号:
    23500111
  • 财政年份:
    2011
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Study on Realization of Intuitive Pedestrian Navigation Environments
直观行人导航环境的实现研究
  • 批准号:
    20500085
  • 财政年份:
    2008
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of expression and function of drug transporters in endotoxemia
内毒素血症药物转运蛋白的表达和功能机制
  • 批准号:
    20590587
  • 财政年份:
    2008
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular pharmacokinetic studies on changes in the expression and function of drug transporters in endotoxemia
内毒素血症药物转运蛋白表达和功能变化的分子药代动力学研究
  • 批准号:
    17590500
  • 财政年份:
    2005
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Experimental study on the inverse GPS
逆向GPS实验研究
  • 批准号:
    15360199
  • 财政年份:
    2003
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Investigation of drug transport function through biological membranes and physiological role in endotoxemia
通过生物膜的药物转运功能及其在内毒素血症中的生理作用的研究
  • 批准号:
    13672417
  • 财政年份:
    2001
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of physiological role of nitric oxide (NO) and cytokines in endotoxemia
阐明一氧化氮 (NO) 和细胞因子在内毒素血症中的生理作用
  • 批准号:
    11672296
  • 财政年份:
    1999
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Inhibition or evasion of P-glycoprotein-mediated drug transport
抑制或逃避 P-糖蛋白介导的药物转运
  • 批准号:
    10568723
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
The epithelial matrisome and drug transport kinetics
上皮基质体和药物转运动力学
  • 批准号:
    10714617
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Construction of drug transport/metabolism research models by improving functions of human tissue-derived cells
通过改善人体组织来源细胞的功能构建药物转运/代谢研究模型
  • 批准号:
    23H02646
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Combining In Vitro and In Silico Models to Investigate Antiretroviral Drug Transport Across the Blood Brain Barrier for the Treatment of HIV-1 Infection in the Brain
结合体外和计算机模型研究抗逆转录病毒药物跨血脑屏障转运以治疗大脑中的 HIV-1 感染
  • 批准号:
    10838759
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Numerical Modelling of Blood Flow and Drug Transport in the Human Blood
人体血液中血流和药物转运的数值模拟
  • 批准号:
    576204-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Vanier Canada Graduate Scholarship Tri-Council - Doctoral 3 years
Junction of drug transport and lipid transport
药物转运和脂质转运的结合点
  • 批准号:
    22K19134
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Liquid-infused tympanostomy tubes with novel material design for efficient drug transport
采用新颖材料设计的液体灌注鼓膜造口管可实现高效药物运输
  • 批准号:
    10324862
  • 财政年份:
    2022
  • 资助金额:
    $ 1.98万
  • 项目类别:
Molecular mechanism of copper and platinum drug transport in human cells
铜铂药物在人体细胞内转运的分子机制
  • 批准号:
    444981
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Operating Grants
Regulation of Drug Transport Proteins and Drug Metabolizing Enzymes by Nuclear Receptors
核受体对药物转运蛋白和药物代谢酶的调节
  • 批准号:
    RGPIN-2016-05056
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Discovery Grants Program - Individual
Modeling mutant PfCRT-mediated drug transport to predict the emergence of piperaquine-resistant Plasmodium falciparum malaria
模拟突变 PfCRT 介导的药物转运以预测耐哌喹恶性疟原虫疟疾的出现
  • 批准号:
    10153252
  • 财政年份:
    2021
  • 资助金额:
    $ 1.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了